Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Evaluating quality of decision-making processes in medicines’ development, regulatory review and health technology assessment: a systematic review of the literature

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Presentation
  • By: BUJAR, Magdalena (Centre for Innovation in Regulatory Science, EC1N8JS, United Kingdom)
  • Co-author(s): Magdalena Bujar: Centre for Innovation in Regulatory Science, EC1N8JS, United Kingdom
    Neil McAuslane: Centre for Innovation in Regulatory Science, EC1N8JS, United Kingdom
    Sam Salek: Department of Pharmacy, Pharmacology & Postgraduate Medicine, University of Hertfordshire, Hatfield, United Kingdom
    Stuart Walker: Centre for Innovation in Regulatory Science, EC1N8JS, United Kingdom
  • Abstract:

    Backgrounds

    Although the quality of decision making in the development, regulatory review and health technology assessment (HTA) influences the delivery of medicines, it is not certain whether suitable techniques exist for formally assessing this within agencies and companies.

    Aims

    To identify current techniques (tools, questionnaires or

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses